GSK has been found guilty of bringing discredit on the pharma industry after a complainan | GSK has been found guilty of ...

The FDA will remove industry representatives from advisory committees and replace them with patients and caregivers ...

Understanding those ingredients, will impart you the essentials of the pharmaceutical market in Egypt. GSK has understood the game of access in Egypt earlier than other companies. By buying two ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are creating turbulence within the Pharma sector.

Trump administration probing extent to which pharmaceutical imports may threaten national security, a likely prelude to ...

The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across the blood-brain barrier.

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

GSK has continued to flesh out its neuroscience strategy with a 2 billion pound sterling ($2.5 billion) deal to use a South ...

GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.

Pharmaceuticals are the next Trump tariff battleground - what will they mean for the NHS? - TRUMP TARIFFS: UK-based drug ...

North Carolina is listed as a location for the manufacture of AstraZeneca and Sanofi's respiratory syncytial virus (RSV) prevention antibody, nirsevimab, as well as for GSK's two-drug HIV regimen ...

It also makes it more expensive to bring drugs to market and could harm pharma companies' profits if they absorb some of the increased costs. As for investors, GSK and AstraZeneca are trying to ...